Brevan Howard Capital Management LP Arrowhead Pharmaceuticals, Inc. Transaction History
Brevan Howard Capital Management LP
- $13.9 Billion
- Q4 2024
A detailed history of Brevan Howard Capital Management LP transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 34,556 shares of ARWR stock, worth $654,490. This represents 0.0% of its overall portfolio holdings.
Number of Shares
34,556
Previous 10,403
232.17%
Holding current value
$654,490
Previous $201,000
222.89%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ARWR
# of Institutions
305Shares Held
95.9MCall Options Held
523KPut Options Held
493K-
Black Rock Inc. New York, NY15.7MShares$297 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.2MShares$231 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY11.1MShares$210 Million3.04% of portfolio
-
State Street Corp Boston, MA6.02MShares$114 Million0.0% of portfolio
-
Slate Path Capital LP New York, NY5.23MShares$99.1 Million1.89% of portfolio
About ARROWHEAD PHARMACEUTICALS, INC.
- Ticker ARWR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 105,849,000
- Market Cap $2B
- Description
- Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...